Trulieve (CSE: TRUL) (OTC: TCNNF) to Purchase Land for Indoor Cultivation Use
Company making a significant investment in the growth of the company
TORONTO - May 30, 2019 (Investorideas.com Newswire) Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE: TRUL & OTC: TCNNF) today announced that the Company has acquired 84.97 acres of land in Jefferson County, Florida which will be used to construct a 750,000 square foot, state-of-the-art indoor growing facility. The facility will be constructed in phases and will be largely automated. Its proximity to Trulieve's production facility in Midway, Florida will allow for convenient transport for processing of the product. It is expected to bring up to 300 jobs to the area.
"Trulieve's need for additional cultivation is being met with this new facility. The new site will supply us with additional product allowing us to meet the growing demands of Florida's patients at a relatively low cost." said Kim Rivers, CEO of Trulieve. "We are excited to implement these new techniques and experience the enhancements and efficiencies these new methods will bring to our cultivation capabilities."
Trulieve is a vertically integrated "seed to sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
To learn more about Trulieve, visit www.Trulieve.com.
SOURCE Trulieve Cannabis Corp.
For further information:
Lynn Ricci, Director, Investor Relations, 850-270-5691, IR@trulieve.com
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com